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Exquisite control of intestinal iron absorption prevents iron deficiency and toxic iron overload. Absorption is
modulated by a circulating hormone, hepcidin, which inactivates the iron transporter ferroportin. In this issue
of Cell Metabolism, Vanoaica and colleagues show that absorption is also regulated within the intestinal
epithelium, through production of the iron-sequestering protein H-ferritin.Intestinal absorption of nonheme iron has
been elucidated over the past 15 years
(Figures 1A and 1B; Hentze et al., 2010).
On the apical (luminal) membrane of
absorptive enterocytes, divalent metal
transporter 1 (DMT1) brings reduced iron
(Fe2+) into the cell. This pathway is impor-
tant, and mice lacking intestinal DMT1
succumb to severe iron deficiency early
in life (Gunshin et al., 2005). Some iron is
retained within enterocytes and, ulti-
mately, lost from the body when those
cells are sloughed into the gut lumen
and excreted. Enterocytes store iron in
ferritin, a hollow, 24-subunit heteromul-
timer of light (L) and heavy (H) polypep-
tides that has a large capacity for ferric
oxides. L and H ferritin subunits are
homologous, but only H-ferritin has a
ferroxidase activity essential for iron
incorporation. Mouse embryos lacking
H-ferritin die early in gestation, presum-
ably because they have no means to
sequester (and thus detoxify) intracellular
iron (Ferreira et al., 2000). Ferritin was
previously assumed to have a relatively
passive job in enterocytes. But, a paper
in this issue (Vanoica et al., 2010)
suggests that ferritin may be more than
just an iron sponge—it appears to have
a dynamic role in the regulation of iron
absorption.
Net iron absorption results from trans-
port across the basolateral (serosal)
membrane by ferroportin. Loss of murine
ferroportin also results in enterocyte iron
accumulation and early lethality (Donovan
et al., 2005). A priori, normal regulation of
transepithelial iron transport could result
from control of the activity of either
DMT1 or ferroportin. Characterization of
molecular defects underlying hemochro-
matosis, a common human iron overloaddisease, showed that regulation of cellular
iron export through ferroportin is more
important. Patients with hemochroma-
tosis occasionally have gain-of-function
mutations in ferroportin but more often
have mutations in proteins that regulate
the expression of hepcidin (reviewed in
Hentze et al., 2010), a peptide hormone
produced by the liver, which binds to fer-
roportin and triggers its internalization and
lysosomal degradation (Nemeth et al.,
2004). When the hepcidin/ferroportin
regulatory axis fails, ferroportin activity is
unchecked and iron overload ensues.
Vanoiaca and colleagues selectively
inactivated a floxed H-ferritin gene using
Cre recombinase expressed from the
intestine-specific villin promoter. As ex-
pected, loss of H-ferritin led to an increase
in the labile intracellular iron pool. This
was demonstrated by the disappearance
of iron regulatory protein2 (IRP2), which
binds to mRNA iron regulatory elements
(IREs) in iron-deficient cells and is
degraded when cells have an iron surfeit
(Figure 1C). Both H- and L-ferritin mRNAs
contain IREs in their 50 untranslated
regions and binding of IRPs blocks the
initiation of translation (reviewed in Hentze
et al., 2010). Ferroportin mRNA also
contains a 50 IRE with similar function.
DMT1 mRNA contains a 30 IRE which,
when bound by IRP, stabilizes the
mRNA to increase DMT1 production. As
expected, iron-loaded enterocytes lack-
ing H-ferritin have very little DMT1 but
excess L-ferritin and ferroportin.
Decreased DMT1 might lead to
systemic iron deficiency, but that was
not observed. Instead, Vanoiaca found
that animals lacking intestinal H-ferritin
develop iron overload in spite of de-
creased dietary iron uptake. Surprisingly,Cell Metabolism 12, Siron loading is not prevented by increased
expression of the iron regulatory hormone
hepcidin, which is induced in response
to iron overload but is ineffective in
inactivating ferroportin. Under other cir-
cumstances, hepcidin expression can
increase dramatically and effectively
block iron absorption, but that does not
happen here. Thus, enterocytes without
capacity to store iron in ferritin have
a defect in systemic iron homeostasis, as
well as in cellular iron homeostasis.
This finding has several potential impli-
cations for human disease. First, intes-
tine-specific failure of H-ferritin produc-
tion might be added to the list of genetic
defects causing hemochromatosis. Kato
et al. reported in 2001 that individuals
carrying a sequence variation in the
H-ferritin IRE that increases IRP binding
(and, thus, decreases H-ferritin expres-
sion) develop an iron overload disorder
similar to hemochromatosis, presumably
as a direct result of the noncoding muta-
tion (Kato et al., 2001), but this has
not yet been observed in other popula-
tions. Mutations increasing H-ferritin
expression in the intestine might have
the opposite effect, causing iron defi-
ciency and anemia. Iron deficiency
caused by increased intestinal ferritin
expression, if it exists, is probably rare—
large genome-wide association studies
identifying genes associated with iron-
deficient red blood cell phenotypes did
not point to H-ferritin as a gene with
potential to influence iron status (summa-
rized in Andrews, 2009).
Ferritin may also turn out to be impor-
tant in regulation of iron homeostasis in
other tissues. It is highly expressed in
most parts of the brain, where it has
been implicated in neurodegenerativeeptember 8, 2010 ª2010 Elsevier Inc. 203
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Figure 1. Regulation of Intestinal Iron Absorption and Cellular Iron Homeostasis
(A) The intestinal epithelium is organized in finger-like villi, lined with absorptive enterocytes that arise from
undifferentiated precursors in adjacent crypts. The core of the villus contains blood vessels and
lymphatics (red, blue, yellow). Enterocytes become functional as they migrate up the villus (arrow) and
are discarded into the intestinal lumen after several days.
(B) Net absorption into the circulation requires import of dietary nonheme iron across the apical brush
border membrane by DMT1 and export across the basolateral membrane by ferroportin. Iron retained
within enterocytes is normally stored in ferritin. Hepcidin, a peptide hormone, regulates cellular iron export
by binding to ferroportin and triggering its internalization and degradation in lysosomes (Ly).
(C) Iron regulatory protein (IRP) binds to an untranslated, RNA stem-loop iron-regulatory element (IRE) to
effect post-transcriptional control of expression of iron-regulated mRNAs. 50 and 30 IREs control transla-
tion through different mechanisms. When the intracellular labile iron pool is decreased, 50 IRP binding
blocks translational initiation and 30 IRP binding protects the message from endonuclease activity.
When intracellular iron is increased, IRP is not available to serve these functions, leading to increased
translation of mRNAs carrying 50 IREs and degradation of mRNAs carrying 30 IREs.
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Previewsdiseases. Mutations in L-ferritin cause
a dominant adult-onset movement dis-
order, neuroferritinopathy, characterized
by abnormal ferritin aggregates and iron
accumulation in the basal ganglia (Curtis204 Cell Metabolism 12, September 8, 2010 ªet al., 2001). Interestingly, one group has
found that mice lacking IRP2 develop a
somewhat similar disorder, that responds
to treatment with nitroxide 4-hydroxy-2,2,
6,6-tetramethylpiperidine-N-oxyl (Ghosh2010 Elsevier Inc.et al., 2008). Extrapolating from what we
know now about the intestine, it may be
time to consider a more active role for
ferritin in brain iron homeostasis and
in the pathogenesis of neurodegenerative
processes associated with metal deposi-
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